Le Lézard
Classified in: Health
Subjects: PLW, MAT

A New Seminal Technology Poised to Change the Entire Cannabis Industry


Patented, disruptive, paradigm shifting

STILLWATER, Minn., July 26, 2022 /PRNewswire/ -- On July 26,2022 Vapor Cartridge Technology LLC, based in Stillwater Minnesota, will receive its 8th patent rounding out a groundbreaking patent portfolio that portends the power to truly change the entire herbal and cannabis industries. Vapor Cartridge Technology LLC has invented and patented an FDA approvable environmentally friendly process, for extracting the essential oils/resins from botanical plants (e.g., cannabis) and an FDA approvable device for delivering a pure and exact dose of the extracted oils/resins as a consistently reliable precise inhalable vapor.

It promises to be, far and away, the most cost-efficient manner to deliver cannabinoid vapors as measured by $/mg/ml of cannabinoids in the bloodstream. It will be the only technology that can provide the dose control, formulation control and purity assurance of inhaled botanical vapors required of an FDA approved drug. This technology will result in a paradigm shift in both the Medical and Recreational cannabis markets.

"Once commercialized The Vapor Cartridge Technology will quickly become the medical standard for ingesting cannabinoid drugs in vapor form. And it will become the overwhelming preference of retail recreational adult users," according to a spokesperson for the company.

Vapor Cartridge Technology LLC is currently seeking licensing opportunities for their new technology and have launched data rich website (https://vaporcartridgetechnology.com) towards this objective. The compelling website contains a detailed explanation of the science behind the technology, a competitive analysis, the benefits of the technology, the patent portfolio, potential licensees, and a way to contact the company.

Contact:
Timothy L. McCullough
Vapor Cartridge Technology LLC
Owner
Mobile 651-491-2115
E-Mail: [email protected]

SOURCE Vapor Cartridge Technology LLC


These press releases may also interest you

at 08:35
Vector Laboratories Merges With Absolute Biotech, Significantly Expanding Capabilities as a Critical Component Manufacturer for Life Science Customers
Vector Laboratories, a manufacturing partner of reagents and critical components for the development and production of life sciences tools, diagnostics, and clinical-stage biotherapeutics, today announced its intention to merge with Absolute Biotech,...

at 08:35
Thermo Fisher Scientific Introduces Array-based Solution for Extended Blood Type Research to Support Future Advancements Toward Safer Transfusions
Thermo Fisher Scientific Inc., the world leader in serving science, today introduced the Applied Biosystemstm Axiomtm BloodGenomiXtm Array* and Software, a first-of-its-kind solution for more precise blood genotyping in clinical research. The new...

at 08:35
Simulations Plus Releases GastroPlus® X, The Next Generation PBPK/PBBM Modeling & Simulation Software
Simulations Plus, Inc. , a leading provider of modeling and simulation solutions for the pharmaceutical, biotechnology, chemicals, and consumer goods industries, today announced the release of GastroPlus® X. Branded as GPXtm, this new platform...

at 08:35
Evolus Celebrates Fifth Anniversary of Launching its Flagship Product Jeuveau® at the Women's Wear Daily Beauty CEO Summit
Evolus, Inc. , a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today announced its participation in the Women's Wear Daily (WWD) Beauty CEO Summit. This summit brings together the leading retailers,...

at 08:34
First International Harmony SHR® Robotic Rehabilitation System Installed at Prestigious Chinese University of Hong Kong Medical Centre
Harmonic Bionics announced today that the first Harmony SHR® exoskeleton in Hong Kong has been delivered and installed at the Chinese University of Hong Kong (CUHK) Medical Centre to be utilized in the hospital's rehabilitation program. This marks...

at 08:34
FDA Grants EUA to Wondfo's WELLlifetm COVID-19/Influenza A&B Test Supported by DCN Dx Clinical Research
DCN Dx, a leading contract research organization for in vitro diagnostics, today acknowledges the FDA's Emergency Use Authorization (EUA) of the WELLlifetm COVID-19/Influenza A&B Test, developed by Wondfo USA. This important authorization will enable...

More news about Health...


News published on and distributed by: